• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用主动监测数据识别韩国新冠疫苗接种后的不良反应:一种文本挖掘方法。

Identifying adverse reactions following COVID-19 vaccination in Korea using data from active surveillance: a text mining approach.

作者信息

Lee Hye Ah, Park Bomi, Kim Chung Ho, Kim Yeonjae, Park Hyunjin, Jun Seunghee, Lee Hyelim, Kwon Seunghyun Lewis, Heo Yesul, Lee Hyungmin, Park Hyesook

机构信息

Clinical Trial Center, Ewha Womans University Mokdong Hospital, Seoul, Korea.

COVID-1 9 Vaccine Safety Research Center, Seoul, Korea.

出版信息

Epidemiol Health. 2025;47:e2025034. doi: 10.4178/epih.e2025034. Epub 2025 Jun 30.

DOI:10.4178/epih.e2025034
PMID:40635461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12425858/
Abstract

OBJECTIVES

Unstructured text data collected through vaccine safety surveillance systems can identify previously unreported adverse reactions and provide critical information to enhance these systems. This study explored adverse reactions using text data collected through an active surveillance system following coronavirus disease 2019 (COVID-19) vaccination.

METHODS

We performed text mining on 2,608 and 2,054 records from 2 survey seasons (2023-2024 and 2024-2025), in which participants reported health conditions experienced within 7 days of vaccination using free-text responses. Frequency analysis was conducted to identify key terms, followed by subgroup analyses by sex, age, and concomitant influenza vaccination. In addition, semantic network analysis was used to examine terms reported together.

RESULTS

The analysis identified several common (≥1%) adverse events, such as respiratory symptoms, sleep disturbances, lumbago, and indigestion, which had not been frequently noted in prior literature. Moreover, less frequent (≥0.1 to <1.0%) adverse reactions affecting the eyes, ears, and oral cavity were also detected. These adverse reactions did not differ significantly in frequency based on the presence or absence of simultaneous influenza vaccination. Co-occurrence analysis and estimation of correlation coefficients further revealed associations between frequently co-reported symptoms.

CONCLUSIONS

This study utilized text mining to uncover previously unrecognized adverse reactions associated with COVID-19 vaccination, thereby broadening our understanding of the vaccine's safety profile. The insights obtained may inform future investigations into vaccine-related adverse reactions and improve the processing of text data in surveillance systems.

摘要

目的

通过疫苗安全监测系统收集的非结构化文本数据可识别先前未报告的不良反应,并为加强这些系统提供关键信息。本研究利用通过2019冠状病毒病(COVID-19)疫苗接种后主动监测系统收集的文本数据,探索不良反应情况。

方法

我们对来自2个调查季节(2023 - 2024年和2024 - 2025年)的2608条和2054条记录进行了文本挖掘,在这些记录中,参与者使用自由文本回复报告了接种疫苗后7天内经历的健康状况。进行频率分析以识别关键术语,随后按性别、年龄和同时接种流感疫苗情况进行亚组分析。此外,使用语义网络分析来检查共同报告的术语。

结果

分析确定了几种常见(≥1%)的不良事件,如呼吸道症状、睡眠障碍、腰痛和消化不良,这些在先前的文献中并不常见。此外,还检测到影响眼睛、耳朵和口腔的频率较低(≥0.1%至<1.0%)的不良反应。这些不良反应在是否同时接种流感疫苗方面,频率没有显著差异。共现分析和相关系数估计进一步揭示了频繁共同报告症状之间的关联。

结论

本研究利用文本挖掘揭示了与COVID-19疫苗接种相关的先前未被认识的不良反应,从而拓宽了我们对疫苗安全性概况的理解。所获得的见解可能为未来对疫苗相关不良反应的调查提供信息,并改善监测系统中文本数据的处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/8ead1205344e/epih-47-e2025034f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/197358f0930e/epih-47-e2025034f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/7956fb7bae2a/epih-47-e2025034f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/44c23f13be5f/epih-47-e2025034f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/8ead1205344e/epih-47-e2025034f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/197358f0930e/epih-47-e2025034f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/7956fb7bae2a/epih-47-e2025034f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/44c23f13be5f/epih-47-e2025034f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f764/12425858/8ead1205344e/epih-47-e2025034f4.jpg

相似文献

1
Identifying adverse reactions following COVID-19 vaccination in Korea using data from active surveillance: a text mining approach.利用主动监测数据识别韩国新冠疫苗接种后的不良反应:一种文本挖掘方法。
Epidemiol Health. 2025;47:e2025034. doi: 10.4178/epih.e2025034. Epub 2025 Jun 30.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Post-pandemic planning for maternity care for local, regional, and national maternity systems across the four nations: a mixed-methods study.针对四个地区的地方、区域和国家孕产妇保健系统的疫情后规划:一项混合方法研究。
Health Soc Care Deliv Res. 2025 Sep;13(35):1-25. doi: 10.3310/HHTE6611.
4
COVID-19 vaccination pharmacovigilance in Khojaly district, Uzbekistan: an epidemiological evaluation.乌兹别克斯坦霍贾利区新冠疫苗接种的药物警戒:一项流行病学评估
Front Public Health. 2025 Jul 2;13:1520821. doi: 10.3389/fpubh.2025.1520821. eCollection 2025.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
A post-marketing safety surveillance study on vaccines in Chongqing, China from 2006 to 2021: Using a nationwide spontaneous reporting database with multiple data mining methods.2006年至2021年中国重庆疫苗上市后安全性监测研究:利用全国性自发报告数据库及多种数据挖掘方法
Hum Vaccin Immunother. 2025 Dec;21(1):2538353. doi: 10.1080/21645515.2025.2538353. Epub 2025 Aug 27.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Vaccines for preventing infections in adults with haematological malignancies.用于预防血液系统恶性肿瘤成人感染的疫苗。
Cochrane Database Syst Rev. 2025 May 21;5(5):CD015530. doi: 10.1002/14651858.CD015530.pub2.
9
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
10
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.

本文引用的文献

1
Active Surveillance for Safety Monitoring of XBB.1.5-Containing COVID-19 mRNA Vaccines in Korea.韩国使用 XBB.1.5 含新冠 mRNA 疫苗的主动监测安全性监测。
J Korean Med Sci. 2024 Nov 11;39(43):e309. doi: 10.3346/jkms.2024.39.e309.
2
Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly.评估老年人同时接种流感疫苗和 COVID-19 疫苗决策的决定因素。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2346966. doi: 10.1080/21645515.2024.2346966. Epub 2024 May 13.
3
Twenty Years of Progress and the Way Forward: Immunization Registry Information System in Korea.
二十年的进展与未来方向:韩国免疫登记信息系统。
J Korean Med Sci. 2024 Apr 1;39(12):e119. doi: 10.3346/jkms.2024.39.e119.
4
Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea.2019冠状病毒病疫苗的安全性监测:2021年2月26日至2022年6月4日,大韩民国
Clin Exp Pediatr. 2023 Oct;66(10):415-423. doi: 10.3345/cep.2022.00815. Epub 2023 Jun 13.
5
Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial.新型冠状病毒肺炎和流感疫苗接种的时间与顺序(TACTIC):一项单盲、安慰剂对照的随机临床试验。
Lancet Reg Health Eur. 2023 Apr 12;29:100628. doi: 10.1016/j.lanepe.2023.100628. eCollection 2023 Jun.
6
Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study.大规模社交媒体数据中 COVID-19 症状的趋势和共现网络:信息监测研究。
J Med Internet Res. 2023 Mar 14;25:e45419. doi: 10.2196/45419.
7
When to update COVID-19 vaccine composition.何时更新新冠病毒疫苗的成分。
Nat Med. 2023 Apr;29(4):776-780. doi: 10.1038/s41591-023-02220-y.
8
The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC's COVID-19 pandemic response.v-safe 疫苗接种后健康状况监测:美国疾病预防控制中心应对 COVID-19 大流行期间的主动疫苗安全监测。
Vaccine. 2023 Feb 10;41(7):1310-1318. doi: 10.1016/j.vaccine.2022.12.031. Epub 2023 Jan 23.
9
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.2021 年 7 月 1 日至 2022 年 6 月 30 日,疫苗不良事件报告系统(VAERS)中 mRNA COVID-19 疫苗与季节性流感灭活疫苗联合接种的安全性。
Vaccine. 2023 Mar 10;41(11):1859-1863. doi: 10.1016/j.vaccine.2022.12.069. Epub 2023 Jan 9.
10
Safety Monitoring of COVID-19 Vaccines: Perspective from the European Medicines Agency.COVID-19 疫苗的安全性监测:来自欧洲药品管理局的观点。
Clin Pharmacol Ther. 2023 Jun;113(6):1223-1234. doi: 10.1002/cpt.2828. Epub 2023 Feb 6.